Matches in DBpedia 2014 for { ?s ?p <http://dbpedia.org/class/yago/MonoclonalAntibody115029781> . }
- Abagovomab type MonoclonalAntibody115029781.
- Abciximab type MonoclonalAntibody115029781.
- Abzyme type MonoclonalAntibody115029781.
- Adecatumumab type MonoclonalAntibody115029781.
- Alacizumab_pegol type MonoclonalAntibody115029781.
- Alemtuzumab type MonoclonalAntibody115029781.
- Amatuximab type MonoclonalAntibody115029781.
- Anatumomab_mafenatox type MonoclonalAntibody115029781.
- Apolizumab type MonoclonalAntibody115029781.
- Aselizumab type MonoclonalAntibody115029781.
- Atinumab type MonoclonalAntibody115029781.
- Atorolimumab type MonoclonalAntibody115029781.
- Bavituximab type MonoclonalAntibody115029781.
- Bectumomab type MonoclonalAntibody115029781.
- Belimumab type MonoclonalAntibody115029781.
- Benralizumab type MonoclonalAntibody115029781.
- Bi-specific_T-cell_engager type MonoclonalAntibody115029781.
- Bispecific_monoclonal_antibody type MonoclonalAntibody115029781.
- Bivatuzumab type MonoclonalAntibody115029781.
- Bivatuzumab_mertansine type MonoclonalAntibody115029781.
- Blinatumomab type MonoclonalAntibody115029781.
- Brentuximab_vedotin type MonoclonalAntibody115029781.
- Cancer_immunotherapy type MonoclonalAntibody115029781.
- Cantuzumab type MonoclonalAntibody115029781.
- Cantuzumab_mertansine type MonoclonalAntibody115029781.
- Cantuzumab_ravtansine type MonoclonalAntibody115029781.
- Catumaxomab type MonoclonalAntibody115029781.
- Cedelizumab type MonoclonalAntibody115029781.
- Cetuximab type MonoclonalAntibody115029781.
- Chemically_linked_Fab type MonoclonalAntibody115029781.
- Citatuzumab_bogatox type MonoclonalAntibody115029781.
- Cixutumumab type MonoclonalAntibody115029781.
- Clenoliximab type MonoclonalAntibody115029781.
- Crenezumab type MonoclonalAntibody115029781.
- Dacetuzumab type MonoclonalAntibody115029781.
- Daclizumab type MonoclonalAntibody115029781.
- Daratumumab type MonoclonalAntibody115029781.
- Denosumab type MonoclonalAntibody115029781.
- Detumomab type MonoclonalAntibody115029781.
- Drozitumab type MonoclonalAntibody115029781.
- Ecromeximab type MonoclonalAntibody115029781.
- Edobacomab type MonoclonalAntibody115029781.
- Edrecolomab type MonoclonalAntibody115029781.
- Elotuzumab type MonoclonalAntibody115029781.
- Elsilimomab type MonoclonalAntibody115029781.
- Enavatuzumab type MonoclonalAntibody115029781.
- Enokizumab type MonoclonalAntibody115029781.
- Ensituximab type MonoclonalAntibody115029781.
- Epratuzumab type MonoclonalAntibody115029781.
- Erlizumab type MonoclonalAntibody115029781.
- Ertumaxomab type MonoclonalAntibody115029781.
- Etaracizumab type MonoclonalAntibody115029781.
- Etrolizumab type MonoclonalAntibody115029781.
- Exbivirumab type MonoclonalAntibody115029781.
- Faralimomab type MonoclonalAntibody115029781.
- Farletuzumab type MonoclonalAntibody115029781.
- Felvizumab type MonoclonalAntibody115029781.
- Ficlatuzumab type MonoclonalAntibody115029781.
- Figitumumab type MonoclonalAntibody115029781.
- Flanvotumab type MonoclonalAntibody115029781.
- Fontolizumab type MonoclonalAntibody115029781.
- Foralumab type MonoclonalAntibody115029781.
- Foravirumab type MonoclonalAntibody115029781.
- Fresolimumab type MonoclonalAntibody115029781.
- Galiximab type MonoclonalAntibody115029781.
- Gantenerumab type MonoclonalAntibody115029781.
- Gavilimomab type MonoclonalAntibody115029781.
- Gevokizumab type MonoclonalAntibody115029781.
- Girentuximab type MonoclonalAntibody115029781.
- Glembatumumab_vedotin type MonoclonalAntibody115029781.
- Gomiliximab type MonoclonalAntibody115029781.
- HuMax type MonoclonalAntibody115029781.
- Human_anti-mouse_antibody type MonoclonalAntibody115029781.
- Humanized_antibody type MonoclonalAntibody115029781.
- Ibalizumab type MonoclonalAntibody115029781.
- Ibritumomab_tiuxetan type MonoclonalAntibody115029781.
- Icrucumab type MonoclonalAntibody115029781.
- Indatuximab_ravtansine type MonoclonalAntibody115029781.
- Inolimomab type MonoclonalAntibody115029781.
- Inotuzumab_ozogamicin type MonoclonalAntibody115029781.
- Ipilimumab type MonoclonalAntibody115029781.
- Iratumumab type MonoclonalAntibody115029781.
- Itolizumab type MonoclonalAntibody115029781.
- Keliximab type MonoclonalAntibody115029781.
- Labetuzumab type MonoclonalAntibody115029781.
- Lebrikizumab type MonoclonalAntibody115029781.
- Lemalesomab type MonoclonalAntibody115029781.
- Lerdelimumab type MonoclonalAntibody115029781.
- Lexatumumab type MonoclonalAntibody115029781.
- Libivirumab type MonoclonalAntibody115029781.
- Lintuzumab type MonoclonalAntibody115029781.
- Lorvotuzumab_mertansine type MonoclonalAntibody115029781.
- Lucatumumab type MonoclonalAntibody115029781.
- Lumiliximab type MonoclonalAntibody115029781.
- Mapatumumab type MonoclonalAntibody115029781.
- Maslimomab type MonoclonalAntibody115029781.
- Matuzumab type MonoclonalAntibody115029781.
- Mavrilimumab type MonoclonalAntibody115029781.
- Metelimumab type MonoclonalAntibody115029781.
- Milatuzumab type MonoclonalAntibody115029781.